Predictors of successful whole-body hyperthermia in cancer patients: target temperature achievement and safety analysis

Aim: This study aimed to investigate the effectiveness and safety of whole-body hyperthermia (WBH) in cancer patients, identifying predictive factors for successful treatment (reaching target temperature ≥ 38.5 °C) and assessing adverse effects. Methods: We conducted a retrospective analysis of 397...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hohneck, Anna (VerfasserIn) , Schmitz-Solheid, Vivien (VerfasserIn) , Gencer, Deniz (VerfasserIn) , Schroeder, Maik (VerfasserIn) , Rieß, Hartmut (VerfasserIn) , Gerhards, Annette (VerfasserIn) , Burkholder, Iris (VerfasserIn) , Heckel-Reusser, Stefan (VerfasserIn) , Gottfried, Julia (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 August 2025
In: Cancers
Year: 2025, Jahrgang: 17, Heft: 16, Pages: 1-13
ISSN:2072-6694
DOI:10.3390/cancers17162716
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers17162716
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/17/16/2716
Volltext
Verfasserangaben:Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz

MARC

LEADER 00000caa a2200000 c 4500
001 1940752906
003 DE-627
005 20251112134437.0
007 cr uuu---uuuuu
008 251110s2025 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers17162716  |2 doi 
035 |a (DE-627)1940752906 
035 |a (DE-599)KXP1940752906 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hohneck, Anna  |d 1990-  |e VerfasserIn  |0 (DE-588)1194587674  |0 (DE-627)1676810412  |4 aut 
245 1 0 |a Predictors of successful whole-body hyperthermia in cancer patients  |b target temperature achievement and safety analysis  |c Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz 
246 1 |i Titel des übergeordneten Special issue  |a Integrated management of cancer (2nd edition) 
264 1 |c 21 August 2025 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.11.2025 
520 |a Aim: This study aimed to investigate the effectiveness and safety of whole-body hyperthermia (WBH) in cancer patients, identifying predictive factors for successful treatment (reaching target temperature ≥ 38.5 °C) and assessing adverse effects. Methods: We conducted a retrospective analysis of 397 cancer patients receiving a total of 855 WBH treatment sessions at a single institution between January 2018 and December 2018. Results: A total of 855 WBH treatments were performed on 397 patients (76.6% female; median age 58 years). The most common cancer types included breast cancer (52.4%), followed by prostate cancer (13.1%) and gynecological cancers (10.6%), with 54.7% of patients having metastatic disease. Target temperature was reached in 90.1% (770 of 855) of sessions, with a median treatment time of 202 min and maximum temperature of 40.4 °C. Common side effects included headache (54.9%), skin reactions (11.7%), and cardiac effects (9.4%), with no serious adverse events. Serum creatinine (p = 0.01, OR 0.30, 95% CI: 0.11-0.78) and secale cornutum/galena co-medication during WBH (p < 0.001, OR 0.26 [0.12, 0.54]) emerged as independent predictors of achieving target temperature in multivariate analysis. Both elevated creatinine levels and the use of secale cornutum/galena were associated with an approximately 70% lower probability of achieving the target temperature. Conclusions: WBH demonstrates safety in cancer patients with high success rates in reaching target temperatures. Both elevated creatinine levels and the use of secale cornutum/galena were associated with a lower chance of reaching the target temperature and thus impacting and predicting WBH success. 
650 4 |a integrative oncology 
650 4 |a safety 
650 4 |a serum creatinine 
650 4 |a whole-body hyperthermia 
700 1 |a Schmitz-Solheid, Vivien  |d 1993-  |e VerfasserIn  |0 (DE-588)138120693X  |0 (DE-627)1940753627  |4 aut 
700 1 |a Gencer, Deniz  |d 1980-  |e VerfasserIn  |0 (DE-588)140107940  |0 (DE-627)616027850  |0 (DE-576)314627332  |4 aut 
700 1 |a Schroeder, Maik  |e VerfasserIn  |4 aut 
700 1 |a Rieß, Hartmut  |d 1962-  |e VerfasserIn  |0 (DE-588)1145733352  |0 (DE-627)100688985X  |0 (DE-576)168771721  |4 aut 
700 1 |a Gerhards, Annette  |d 1969-  |e VerfasserIn  |0 (DE-588)12136206X  |0 (DE-627)705410110  |0 (DE-576)181479397  |4 aut 
700 1 |a Burkholder, Iris  |e VerfasserIn  |0 (DE-588)1176548557  |0 (DE-627)104754671X  |0 (DE-576)516671278  |4 aut 
700 1 |a Heckel-Reusser, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Gottfried, Julia  |d 1979-  |e VerfasserIn  |0 (DE-588)101689662X  |0 (DE-627)671850490  |0 (DE-576)352810106  |4 aut 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 17(2025), 16, Artikel-ID 2716, Seite 1-13  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysis 
773 1 8 |g volume:17  |g year:2025  |g number:16  |g elocationid:2716  |g pages:1-13  |g extent:13  |a Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysis 
856 4 0 |u https://doi.org/10.3390/cancers17162716  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/17/16/2716  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251110 
993 |a Article 
994 |a 2025 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 10  |y j 
998 |g 1176548557  |a Burkholder, Iris  |m 1176548557:Burkholder, Iris  |d 140000  |e 140000PB1176548557  |k 0/140000/  |p 7 
998 |g 140107940  |a Gencer, Deniz  |m 140107940:Gencer, Deniz  |d 60000  |e 60000PG140107940  |k 0/60000/  |p 3 
998 |g 138120693X  |a Schmitz-Solheid, Vivien  |m 138120693X:Schmitz-Solheid, Vivien  |d 60000  |e 60000PS138120693X  |k 0/60000/  |p 2 
998 |g 1194587674  |a Hohneck, Anna  |m 1194587674:Hohneck, Anna  |d 60000  |d 61000  |d 60000  |d 910000  |d 910100  |e 60000PH1194587674  |e 61000PH1194587674  |e 60000PH1194587674  |e 910000PH1194587674  |e 910100PH1194587674  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1940752906  |e 4801901344 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"text":"17(2025), 16, Artikel-ID 2716, Seite 1-13","volume":"17","extent":"13","year":"2025","pages":"1-13","issue":"16"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"disp":"Predictors of successful whole-body hyperthermia in cancer patients target temperature achievement and safety analysisCancers","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel","dateIssuedKey":"2009"}],"recId":"614095670","id":{"zdb":["2527080-1"],"eki":["614095670"],"issn":["2072-6694"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27.05.2020"],"pubHistory":["1.2009 -"],"language":["eng"]}],"title":[{"title":"Predictors of successful whole-body hyperthermia in cancer patients","title_sort":"Predictors of successful whole-body hyperthermia in cancer patients","subtitle":"target temperature achievement and safety analysis"}],"physDesc":[{"extent":"13 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3390/cancers17162716"],"eki":["1940752906"]},"recId":"1940752906","name":{"displayForm":["Anna Lena Hohneck, Vivien Schmitz-Solheid, Deniz Gencer, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried and Ralf-Dieter Hofheinz"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"21 August 2025"}],"language":["eng"],"titleAlt":[{"title":"Integrated management of cancer (2nd edition)"}],"note":["Gesehen am 10.11.2025"],"person":[{"role":"aut","family":"Hohneck","display":"Hohneck, Anna","given":"Anna"},{"display":"Schmitz-Solheid, Vivien","role":"aut","family":"Schmitz-Solheid","given":"Vivien"},{"given":"Deniz","display":"Gencer, Deniz","role":"aut","family":"Gencer"},{"display":"Schroeder, Maik","role":"aut","family":"Schroeder","given":"Maik"},{"display":"Rieß, Hartmut","role":"aut","family":"Rieß","given":"Hartmut"},{"display":"Gerhards, Annette","role":"aut","family":"Gerhards","given":"Annette"},{"family":"Burkholder","role":"aut","display":"Burkholder, Iris","given":"Iris"},{"given":"Stefan","role":"aut","family":"Heckel-Reusser","display":"Heckel-Reusser, Stefan"},{"given":"Julia","family":"Gottfried","role":"aut","display":"Gottfried, Julia"},{"given":"Ralf-Dieter","family":"Hofheinz","role":"aut","display":"Hofheinz, Ralf-Dieter"}]} 
SRT |a HOHNECKANNPREDICTORS2120